Related Experiment Video
Updated: Aug 22, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Potential Role of Circulating Biomarkers in Peripheral Artery Disease
Alek C Keegan1, Philip Greenland2,3, Donald M Lloyd-Jones4
1Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Purpose Of Review:
To review evidence on the role of circulating biomarkers associated with lower extremity peripheral artery disease (PAD) and adverse outcomes in people with PAD.
Recent Findings:
The ankle-brachial index (ABI) is a non-invasive, guideline-recommended test to diagnose PAD. Circulating biomarkers may offer additional insight into early detection of PAD and risk stratification of adverse events in people with PAD. Observational studies show that higher levels of inflammatory biomarkers (such as C-reactive protein, interleukin-6, soluble intracellular adhesion molecule-1), thrombosis biomarkers (such as D-dimer, fibrinogen), cardiac biomarkers (such as troponin, N-terminal pro-brain natriuretic peptide, lipoprotein A), and omic markers are associated with increased risk of developing PAD. Some of these markers are also associated with severity and adverse outcomes in people with PAD. While association studies have shown links between circulating biomarkers and PAD, no single biomarker or combination of markers is currently guideline-recommended for routine clinical use in diagnosis or management of PAD due to absence of clinical trial data showing that circulating biomarkers definitively improve outcomes in PAD. The current state of biomarkers in PAD suggests that further study is needed to determine whether biomarker-guided therapy will improve diagnosis or clinical outcomes for people at risk and people with PAD.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Peripheral Artery Disease III: Interprofessional Care
